Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
Sign Up
Log in

Antigenics Inc
OTC:ANTI

Watchlist Manager
Antigenics Inc Logo
Antigenics Inc
OTC:ANTI
Watchlist
Price: 0 USD Market Closed
Market Cap: $0
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-16%
5Y
-95%
10Y
-
Investing Cash Flow
+
3Y
-
5Y
-
10Y
-
Financing Cash Flow
+
3Y
-
5Y
+46%
10Y
-

Cash Flow Statement
Antigenics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Jun-1992 Sep-1992 Dec-1992 Mar-1993 Jun-1993 Sep-1993 Dec-1993 Mar-1994 Jun-1994 Sep-1994 Dec-1994 Mar-1995 Jun-1995 Sep-1995 Dec-1995 Mar-1996 Jun-1996 Sep-1996 Dec-1996 Mar-1997 Jun-1997 Sep-1997 Dec-1997 Mar-1998 Jun-1998 Sep-1998 Dec-1998 Mar-1999 Jun-1999 Sep-1999 Dec-1999 Mar-2000 Jun-2000 Sep-2000 Dec-2000 Mar-2001
Operating Cash Flow
Net Income
(5)
(4)
(5)
(5)
(5)
(6)
(6)
(7)
(8)
(9)
(9)
(9)
(8)
(16)
(17)
(17)
(18)
(10)
(8)
(9)
(10)
(14)
(17)
(19)
(21)
(21)
(18)
(17)
(10)
(9)
(14)
(18)
(20)
(19)
(18)
(14)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Other Non-Cash Items
0
0
0
1
1
1
0
1
1
1
0
0
0
8
9
9
9
2
1
1
1
4
4
4
4
1
1
2
2
2
3
(2)
(0)
2
(2)
2
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
0
0
(0)
(0)
(0)
(0)
0
0
0
0
0
(0)
1
1
1
1
0
(1)
(1)
(1)
(1)
(0)
1
3
2
3
4
2
0
(1)
(2)
1
(3)
(2)
1
(2)
Cash from Operating Activities
(4)
N/A
(4)
+12%
(4)
-6%
(4)
-8%
(5)
-8%
(5)
-3%
(5)
-8%
(6)
-8%
(7)
-18%
(7)
-10%
(8)
-7%
(8)
-2%
(7)
+14%
(6)
+7%
(7)
-1%
(7)
-3%
(7)
-10%
(8)
-8%
(8)
+5%
(8)
-10%
(9)
-9%
(10)
-4%
(11)
-12%
(11)
-6%
(14)
-25%
(17)
-18%
(12)
+27%
(12)
-1%
(7)
+44%
(7)
-6%
(13)
-79%
(18)
-40%
(23)
-23%
(18)
+18%
(18)
+1%
(13)
+28%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(2)
(2)
(2)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
0
Other Items
0
(7)
(7)
(3)
(5)
(1)
1
(3)
(2)
1
(2)
(0)
2
6
10
10
(29)
(30)
(33)
(34)
10
6
9
13
14
19
19
4
(4)
4
0
20
19
7
8
(3)
Cash from Investing Activities
(0)
N/A
(7)
-2 850%
(8)
-9%
(4)
+52%
(6)
-57%
(2)
+67%
(0)
+93%
(5)
-3 157%
(4)
+19%
(1)
+77%
(3)
-229%
(1)
+72%
1
N/A
6
+388%
10
+62%
10
-1%
(29)
N/A
(30)
-4%
(33)
-10%
(34)
-2%
10
N/A
6
-43%
8
+48%
12
+37%
13
+11%
17
+35%
17
+0%
4
-79%
(5)
N/A
3
N/A
(0)
N/A
19
N/A
19
0%
7
-63%
8
+7%
(3)
N/A
Financing Cash Flow
Net Issuance of Common Stock
4
15
11
11
11
5
16
16
16
11
0
0
0
0
3
5
39
39
36
34
1
1
0
0
0
0
3
15
15
16
13
1
8
8
8
8
Net Issuance of Debt
0
(3)
0
0
0
0
0
0
1
1
0
0
(0)
(0)
(0)
(0)
(1)
1
1
1
2
(0)
(0)
(0)
1
1
1
2
1
1
1
0
(0)
(0)
(0)
(0)
Cash from Financing Activities
4
N/A
12
+180%
11
-10%
11
0%
11
+1%
5
-55%
16
+231%
16
0%
17
+1%
12
-28%
0
-99%
0
+55%
(0)
N/A
(0)
+12%
3
N/A
5
+71%
38
+660%
40
+6%
37
-7%
35
-5%
2
-94%
0
-91%
0
-79%
(0)
N/A
1
N/A
1
-5%
4
+250%
16
+300%
15
-6%
16
+5%
13
-18%
1
-91%
8
+571%
7
-8%
7
+1%
7
-2%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
(0)
N/A
1
N/A
(1)
N/A
3
N/A
0
-86%
(2)
N/A
11
N/A
6
-45%
6
+0%
4
-40%
(11)
N/A
(9)
+18%
(6)
+32%
(1)
+91%
6
N/A
8
+28%
2
-79%
2
+15%
(4)
N/A
(7)
-98%
3
N/A
(4)
N/A
(2)
+40%
0
N/A
0
-88%
2
+6 167%
9
+395%
8
-17%
4
-54%
12
+239%
0
-98%
2
+1 032%
5
+122%
(4)
N/A
(3)
+17%
(9)
-165%
Free Cash Flow
Free Cash Flow
(5)
N/A
(4)
+15%
(5)
-23%
(5)
-8%
(6)
-9%
(6)
-5%
(6)
0%
(7)
-18%
(8)
-17%
(9)
-8%
(9)
-2%
(9)
+6%
(7)
+17%
(7)
+8%
(7)
-1%
(7)
-3%
(8)
-10%
(8)
-11%
(8)
+5%
(9)
-11%
(10)
-10%
(10)
-3%
(11)
-12%
(13)
-15%
(16)
-23%
(18)
-17%
(14)
+23%
(13)
+7%
(8)
+42%
(8)
-6%
(13)
-67%
(19)
-39%
(23)
-22%
(19)
+17%
(19)
+1%
(13)
+30%

See Also

Summary
ANTI intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANTI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANTI stock valuation using valuation multiples.
Wall Street Estimates
ANTI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANTI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 329,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett